20250179102. Therapeutics Compounds F (Gilead Sciences, .)
THERAPEUTICS COMPOUNDS FOR HIV VIRUS INFECTION
Abstract: the present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. the compounds and compositions provided herein may be used for the treatment or prevention of a retroviridae infection, including an hiv infection.
Inventor(s): Julie Farand, Michael Graupe, Tezcan Guney, Darryl Kato, Jiayao Li, John O. Link, James B. C. Mack, Dong Min Mun, Roland D. Saito, William J. Watkins, Jennifer R. Zhang
CPC Classification: C07F9/095 (ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins ))
Search for rejections for patent application number 20250179102
- Patent Applications
- Gilead Sciences, Inc.
- CPC C07F9/095
- Julie Farand of San Mateo CA US
- Michael Graupe of Pacifica CA US
- Tezcan Guney of Foster City CA US
- Darryl Kato of San Francisco CA US
- Jiayao Li of Foster City CA US
- John O. Link of San Francisco CA US
- James B. C. Mack of San Mateo CA US
- Dong Min Mun of Newark CA US
- Roland D. Saito of San Mateo CA US
- William J. Watkins of Saratoga CA US
- Jennifer R. Zhang of Union City CA US